MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Clinical trials for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE explained in plain language.
Never miss a new study
Get alerted when new MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE trials appear
Sign up with your email to follow new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diet and supplements tested to halt blood cancer before it starts
Prevention Recruiting nowThis study looks at whether a plant-based diet, omega-3 and curcumin supplements, or a placebo can change gut bacteria in people with early blood conditions called MGUS and smoldering multiple myeloma. The goal is to see if these changes might help prevent the conditions from tur…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated May 11, 2026 20:40 UTC
-
Fasting and mediterranean diet tested for blood cancer patients
Symptom relief Recruiting nowThis study looks at whether a diet that includes longer overnight fasting and follows a Mediterranean eating pattern is possible for people with multiple myeloma or its early forms (MGUS or smoldering myeloma). Researchers want to see if participants can stick with the diet and i…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated May 17, 2026 02:01 UTC
-
New italian network aims to catch rare disease earlier
Knowledge-focused Recruiting nowThis study connects Italian hospitals to a specialized center to find AL amyloidosis earlier in people with related blood conditions. Researchers will screen 760 participants using blood tests and track their health over time. The goal is to speed up diagnosis and learn more abou…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated May 17, 2026 02:13 UTC
-
Ohio study aims to track and support myeloma patients while paving way for future cures
Knowledge-focused Recruiting nowThis study is creating a large database of up to 5,000 people in Ohio with plasma cell disorders like multiple myeloma and amyloidosis. Researchers will track treatments, outcomes, and quality of life, while also offering patients access to expert consultations and information ab…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 02:07 UTC
-
Could sleep apnea affect bone marrow in blood cancer patients?
Knowledge-focused Recruiting nowThis study looks at how common sleep apnea is in people with MGUS or multiple myeloma, and whether it changes gene activity in bone marrow. Researchers will collect bone marrow samples during routine biopsies from 200 participants. The goal is to understand the link between sleep…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: Michael Tomasson • Aim: Knowledge-focused
Last updated May 14, 2026 12:01 UTC
-
How do you feel? study asks patients with rare blood conditions
Knowledge-focused Recruiting nowThis study looks at the quality of life of people with two early blood conditions: monoclonal gammopathy of unknown significance (MGUS) and smoldering multiple myeloma. Researchers want to learn about the most common symptoms and concerns these patients face. Participants will fi…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC
-
Can we predict who gets myeloma? new study seeks answers
Knowledge-focused Recruiting nowThis study follows 200 people with early blood conditions (MGUS or smoldering myeloma) that sometimes turn into multiple myeloma. Researchers will track age, blood protein levels, bone marrow cells, and genetic markers to see who progresses and who doesn't. No treatments are give…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 08, 2026 12:03 UTC
-
Can a 2-week diet change gut health in blood cancer precursors?
Knowledge-focused Recruiting nowThis study looks at how a plant-based diet or supplements (omega-3, curcumin, or probiotics) change butyrate levels in stool after 2 weeks. Butyrate is a substance made by gut bacteria that may affect health. The study includes 200 adults with smoldering multiple myeloma or MGUS,…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 06, 2026 16:14 UTC
-
Can we predict who will get myeloma? 1,000-Person study aims to find out
Knowledge-focused Recruiting nowThis study is following 1,000 adults with early signs that can lead to multiple myeloma (a blood cancer). The goal is to learn why some people's condition gets worse while others stay stable. Researchers will use advanced genetic tests to look for key changes in the bone marrow. …
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: University of Miami • Aim: Knowledge-focused
Last updated May 04, 2026 16:24 UTC